Double-Punch cell therapy aims to outsmart tough blood cancers
Disease control
Recruiting now
This early-stage study is testing a new type of cell therapy designed to attack two different targets on cancer cells. It is for patients with multiple myeloma or a type of lymphoma that has come back or stopped responding to standard treatments. The main goal is to see if this t…
Phase: PHASE1 • Sponsor: iCell Gene Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC